Seres Therapeutics, Inc. · NASDAQ:MCRB

Brady Kelly sold 59 Seres Therapeutics, Inc. shares (Form 4)

Traded May 15 to May 18, 2026 · Filed May 19, 2026

From May 15 to May 18, 2026, Brady Kelly (See Remarks) sold 59 Seres Therapeutics, Inc. shares at US$7.53 for US$444, leaving 8,562 shares. Filed May 19, 2026 (Form 4).

Sold
59 shares
Price
US$7.53
Value
US$444
Holding after
8,562 shares
Trading plan
No
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockOption exercise1808,621Direct
May 18, 2026Common StockSale59US$7.538,562Direct

Source

View original at SEC

Related